Bavanthi Balakrishnar
Impact in
-
- Cancer Genomics and Diagnostics
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 3
- Cancer Cells and Metastasis 2
-
- Prostate Cancer Treatment and Research 7
- Renal cell carcinoma treatment 2
- Co-authors
- Howard Gurney (11 shared papers)Mark Wong (6 shared papers)Bo Gao (5 shared papers)Arthur Clements (1 shared paper)Therese M. Becker (8 shared papers)Paul de Souza (9 shared papers)Wei Chua (8 shared papers)Yafeng Ma (7 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Clinical Genitourinary Cancer (3 papers)Cells (2 papers)International Journal of Molecular Sciences (2 papers)The Breast (2 papers)
- Partner nations
- AustraliaNetherlandsGermany
In The Last Decade
Bavanthi Balakrishnar
24 papers receiving 484 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 90
- Pharmacology 54
- Oncology 147
- Hematology 54
- Pulmonary and Respiratory Medicine 146
Countries citing papers authored by Bavanthi Balakrishnar
This map shows the geographic impact of Bavanthi Balakrishnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bavanthi Balakrishnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bavanthi Balakrishnar more than expected).
Fields of papers citing papers by Bavanthi Balakrishnar
This network shows the impact of papers produced by Bavanthi Balakrishnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bavanthi Balakrishnar. The network helps show where Bavanthi Balakrishnar may publish in the future.
Co-authors
The 25 scholars most cited alongside Bavanthi Balakrishnar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 161 | |
| 2 | 2016 | 64 | |
| 3 | 2019 | 56 | |
| 4 | 2016 | 50 | |
| 5 | 2020 | 26 | |
| 6 | 2013 | 23 | |
| 7 | 2017 | 23 | |
| 8 | 2017 | 21 | |
| 9 | 2019 | 11 | |
| 10 | 2016 | 11 | |
| 11 | 2022 | 10 | |
| 12 | 2022 | 9 | |
| 13 | 2014 | 5 | |
| 14 | 2020 | 4 | |
| 15 | 2013 | 2 | |
| 16 | 2022 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 2024 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2021 | 1 |
About Bavanthi Balakrishnar
Bavanthi Balakrishnar is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Cancer Research and Molecular Biology, having authored 25 papers that have together received 487 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (7 papers), Testicular diseases and treatments (4 papers), Cancer Genomics and Diagnostics (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Mass Spectrometry Techniques and Applications (3 papers), Estrogen and related hormone effects (3 papers), Renal cell carcinoma treatment (2 papers) and Cancer Cells and Metastasis (2 papers). The work is most often cited by research in Cancer Research (90 citations), Pharmacology (54 citations), Oncology (147 citations), Hematology (54 citations) and Pulmonary and Respiratory Medicine (146 citations). Bavanthi Balakrishnar has collaborated with scholars based in Australia, Netherlands and Germany. Frequent co-authors include Howard Gurney, Mark Wong, Bo Gao, Arthur Clements, Therese M. Becker, Paul de Souza, Wei Chua, Yafeng Ma, Francis Young and Alison W. S. Luk. Their work appears in journals such as Journal of Clinical Oncology, Clinical Genitourinary Cancer, Cells, International Journal of Molecular Sciences and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.